U.S. Agency Officials Recommend Pausing Use of Johnson & Johnson Vaccine Over Blood Clot Concerns

At least six people have exhibited symptoms of cerebral venous sinus thrombosis within six and 13 days of receiving the vaccine, the CDC and FDA said. Johnson & Johnson will also delay the vaccine’s rollout in Europe.